For years, pharmaceutical serialization has been on the horizon of our industry - a familiar concept, discussed at conferences and anticipated in regulations.

An initiative that creates space to regenerate, connect, and rediscover personal time even during work life.

"Imagine running a marathon without shoes, on uneven terrain and blindfolded."

Analysis of the differences and prospects in the economic and commercial field between Advanced Therapy drugs and traditional drugs

Key tools and strategies for the proper marketing of drugs in the countries of the Eurasian Economic Union - EAEU.

To simplify the collection of clinical trial data, JSB worked on the development of Counterpoint Software

How does the production and supply process change with the advent of Advanced Therapies? The challenges and new scenarios introduced by innovative drugs.

The main changes introduced with MDR EU 2017/745: the procedures for obtaining or renewing a certification for Medical Devices.

The safety of pesticides: reference standards for drugs of plant origin and other preparations based on medicinal plants

For the adaptation to the New Regulations of some Medical Devices, a "Grace Period" is envisaged, a grace period from May 2021 to May 2024.

"Orphan" drugs - How and when can a company launch one in Italy? What are the timelines for approval by the competent authorities?

The advantages of the new Cold Chain Platform (CCP) for drug monitoring throughout the entire distribution chain.

In the first months of 2022, the sixth module of the EUDAMED platform came into force - Further information and general information on the UDI electronic catalog

With the new EU MDR 2017/745, many Medical Devices will change their classification. Read the news of the new regulation.

The use of the eCTD has been mandatory since 2018 for all medicines registered in the European Union. But what is an eCTD? What is it for and how is it created?